A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Chee Wah TanProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeWan Ni ChiaProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeXijian QinPei LiuMark ChenNational Centre for Infectious DiseasesCharles Kevin TiuProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeZhiliang HuCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing, ChinaVivian Chih-Wei ChenProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeBarnaby Edward YoungLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, SingaporeWan Rong SiaProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeYee‐Joo TanInstitute of Molecular and Cell BiologyRandy FooProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeYongxiang YiNanjing Infectious Disease Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, ChinaDavid Chien LyeLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, SingaporeDanielle E. AndersonSingHealth Duke-NUS Global Health Institute, Singapore, Singapore. [email protected]Lin‐Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. [email protected]
2020en
Ochiq kirishBronza
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba